---
title: "Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295842767.md"
description: "On August 13, 2026, Edesa Biotech, Inc. (Nasdaq: EDSA), a company specializing in host-directed therapeutics for immuno-inflammatory diseases, released its financial data for the three and nine months concluding on June 30, 2026. The report also featured an overview of the company's recent business activities."
datetime: "2026-08-13T20:16:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295842767.md)
  - [en](https://longbridge.com/en/news/295842767.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295842767.md)
generator: "portal-rs"
---

# Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results

On August 13, 2026, Edesa Biotech, Inc. (Nasdaq: EDSA), a company specializing in host-directed therapeutics for immuno-inflammatory diseases, released its financial data for the three and nine months concluding on June 30, 2026. The report also featured an overview of the company's recent business activities.

### Related Stocks

- [EDSA.US](https://longbridge.com/en/quote/EDSA.US.md)

## Related News & Research

- [Edesa Biotech Stock Sinks After Fresh Capital Raise](https://longbridge.com/en/news/296475481.md)
- [Zenas Biopharma outlines autoimmune disease pipeline in corporate presentation](https://longbridge.com/en/news/297813603.md)
- [AbbVie Completes Acquisition of Apogee Therapeutics | ABBV Stock News](https://longbridge.com/en/news/297915640.md)
- [Quanta Services announces dividend of R$ 0.03 per unit for Q3 2026](https://longbridge.com/en/news/297931955.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**